Study details
Enrolling now
Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section
Senthil Sadhasivam
NCT IDNCT05380531ClinicalTrials.gov data as of Apr 2026
Target enrollment
600
Study length
about 3.9 years
Ages
18+
Sex
Female only
Locations
4 sites in IN, MO, PA
What this study is about
This trial is testing a new way to manage pain after a C-section. It involves genetic testing before surgery to personalize the treatment approach. The goal is to reduce opioid use and improve outcomes for mothers and babies.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Preoperative Genotyping
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Look at genetic factors predisposing patients to inadequate surgical pain relief with oxycodone
Body systems
Psychiatry / Mental Health